Skip to content

Ginkgo Bioworks DNA Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$141.31M-11.7%$160.07M-6.1%$170.52M-22.7%$220.73M-2.9%$227.33M+0.1%
$222.77M-8.6%$243.77M-9.7%$270.02M-2.8%$277.68M-22.6%$358.53M-15.5%
$172.08M-1.1%$173.97M-6.1%$185.25M-3.8%$192.59M-10.7%$215.6M-12.4%
-$297.68M+3.1%-$307.28M+9.7%-$340.14M-11.4%-$305.32M+34.0%-$462.73M+17.3%
-210.7%-18.7pp-192%+7.5pp-199.5%-61.1pp-138.3%+65.2pp-203.5%+43.0pp
-$298.87M+2.3%-$305.95M+8.0%-$332.42M-7.8%-$308.44M+33.6%-$464.85M+15.1%
-$1.01M-20.1%-$837K-61.3%-$519K+42.0%-$895K-112%-$422K+11.9%
-$240.72M+3.1%-$248.29M+11.1%-$279.16M-15.7%-$241.34M+39.3%-$397.75M+19.9%
-170.3%-15.2pp-155.1%+8.6pp-163.7%-54.4pp-109.3%+65.6pp-175%+43.8pp
-$297.68M+3.1%-$307.28M+9.7%-$340.14M-11.4%-$305.32M+34.0%-$462.73M+17.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Ginkgo Bioworks's revenue?
Ginkgo Bioworks (DNA) generated $141.3M in revenue over the trailing twelve months, down 37.8% year over year.
Is Ginkgo Bioworks profitable?
Ginkgo Bioworks is not currently profitable: it reported a net loss of $304.4M over the trailing twelve months, a -215.4% net margin.
Where does Ginkgo Bioworks's income statement data come from?
Every line is extracted from Ginkgo Bioworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.